Ticker	Volume	Price	Price Delta
DJIA	15,285.10	-9.43	-0.06%
S&P 500	1,647.87	-2.64	-0.16%
Nasdaq	3,451.09	-8.32	-0.24%

Ticker

Volume

Price

Price Delta

DJIA

15,285.10

-9.43

-0.06%

S&P 500

1,647.87

-2.64

-0.16%

Nasdaq

3,451.09

-8.32

-0.24%

Ticker	Volume	Price	Price Delta
STOXX 50	2,764.29	-12.49	-0.45%
FTSE 100	6,654.34	-42.45	-0.63%
DAX	8,305.32	-46.66	-0.56%

Ticker

Volume

Price

Price Delta

STOXX 50

2,764.29

-12.49

-0.45%

FTSE 100

6,654.34

-42.45

-0.63%

DAX

8,305.32

-46.66

-0.56%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Bank Leumi, Gilat, Kardan, Teva: Israel Equity Preview

By Calev Ben-David - 2010-11-30T07:28:49Z

The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the close unless otherwise stated.

The TA-25 Index rose less than 0.1 percent to 1,263.13 in Tel Aviv.

Bank Leumi Le-Israel Ltd. (LUMI IT): Israel’s largest bank posted third-quarter net income of 603 million shekels ($164 million) compared with 534 million shekels a year earlier. Leumi increased 0.5 percent to 17.77 shekels.

Gilat Satellite Networks Ltd. (GILT IT): The developer of satellite network technology completed its acquisition of Wavestream Corp. for about $130 million. Gilat fell 0.7 percent to 17.99 shekels.

Kardan Israel Ltd. (KRIS IT): The real estate investment group’s third-quarter net income rose to 24.9 million shekels from a profit of 33.3 million shekels a year-earlier. Kardan rose 0.5 percent to 8.207 shekels.

Perrigo Inc. (PRGO IT): The manufacturer of over-the- counter pharmaceuticals said its licensor Synthon received final approval from the U.S. Food and Drug Administration for a generic version of Xyzal allergy tablets. Perrigo gained 0.3 percent to 228.5 shekels.

Teva Pharmaceutical Industries Ltd. (TEVA IT): The world’s largest maker of generic drugs’ strategic partner in the distribution of a generic version of Concerta tablets, Impax, is being sued by Alza Corp. for patent infringement in a U.S. District Court in Delaware. Teva rose 0.2 percent to 186.3 shekels.

To contact the reporter on this story: Calev Ben-David in Jerusalem at cbendavid@bloomberg.net

To contact the editor responsible for this story: Peter Hirschberg in Jerusalem at phirschberg@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.